What is LOPJLB’s current signal on SCTX?

LOPJLB’s latest quantitative signal on Scribe Therapeutics Inc. (SCTX) is FLAT. Signals are updated daily.

What market regime is SCTX in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Scribe Therapeutics Inc. (SCTX) do?

Scribe Therapeutics is a clinical-stage biotechnology company focused on developing in vivo CRISPR-based genetic medicines. The company engineers proprietary technologies to target the genetic drivers of disease, with an initial focus on atherosclerotic cardiovascular disease (ASCVD), aiming to shift treatment from chronic care to preventative intervention.

Where is Scribe Therapeutics Inc. based / listed?

Scribe Therapeutics Inc. is based in US, listed on NASDAQ.

Scribe Therapeutics Inc. (SCTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$29.47+0.20%Close

FLAT

[SCORES & PROFILE]

FUND: 1
VALUE: 0
GROWTH: 0
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-

---

[VALUATION]

P/E TTM-

P/E FWD-

SECTOR PE21.68

INDUSTRY PE16.57

P/B-

P/FCF-

EV/EBITDA-

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO-

ND/EBITDA-

BETA0.00

Scribe Therapeutics Inc. (SCTX)

Key stats

Prediction markets

FUNDAMENTALS

Company news